Cardiovascular Systems reported $44.06M in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Abbott ABT:US $ 6505M 1225M
Abiomed ABMD:US $ 204.26M 3.14M
Atricure ATRC:US $ 52.23M 1.85M
Baxter International BAX:US $ 1343M 101M
Becton, Dickinson and BDX:US $ 2254M 93M
Boston Scientific BSX:US $ 2018M 102M
Cardiovascular Systems CSII:US $ 44.06M 6.29M
Dexcom DXCM:US $ 446.9M 29.8M
Genmark Diagnostics GNMK:US $ 19.4M 2.86M
Globus Medical GMED:US $ 171.17M 16M
Hill Rom HRC:US $ 427M 52.5M
Hologic HOLX:US $ 828.1M 126.5M
Inogen INGN:US $ 47.69M 2.65M
Insulet PODD:US $ 188.7M 6M
Intuitive Surgical ISRG:US $ 971.4M 52.3M
Johnson & Johnson JNJ:US $ 16088M 343M
Medtronic MDT:US $ 5350M 72M
Merit Medical Systems MMSI:US $ 120.49M 3.64M
Nuvasive NUVA:US $ 182.18M 34.36M
Resmed RMD:US $ 506.29M 15.59M
Stryker SYK:US $ 2757M 45M
Tandem Diabetes Care TNDM:US $ 96.74M 4.29M
Teleflex TFX:US $ 387.79M 9.77M
Terumo 4543:JP Y 91985M 2274M
Zimmer Biomet Holdings Inc ZBH:US $ 1.34B 102.8M